OLMA Reports $218.5M Offering Proceeds, $505.4M Cash, Palazestrant Phase 3 Data Fall 2026
Olema Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $12.71
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS